Author | Jason M. Broderick

Articles

FDA approves avelumab as frontline maintenance in urothelial carcinoma

July 01, 2020

Article

The FDA has approved the PD-L1 inhibitor avelumab for the frontline maintenance treatment of patients with locally advanced or metastatic urothelial carcinoma.

AUA 2020: Disorders of ejaculation guidelines hailed as “most scientifically rigorous to date”

June 30, 2020

Article

Alan W. Shindel, MD, provides an expert summary and analysis of the 2020 AUA Guidelines for Disorders of Ejaculation.

Sulopenem hits key end point in phase 3 uncomplicated UTI trial

June 29, 2020

Article

The novel oral penem anti-infective compound sulopenem showed stronger clinical activity than ciprofloxacin in patients with uncomplicated urinary tract infections with quinolone resistant pathogens, according to findings from the phase 3 SURE1 trial.

AUA 2020: Experts explain new guideline for advanced prostate cancer

June 29, 2020

Article

William Lowrance, MD, and Michael S. Cookson, MD, highlight the core components of the new AUA Guideline for Advanced Prostate Cancer.